Sanofi
UnclaimedSanofi is a research-driven biopharmaceutical company developing medicines and vaccines to improve people’s lives.
Overview
Sanofi is an R&D-driven, AI-powered biopharmaceutical company that discovers, develops, and delivers medicines and vaccines for people worldwide. It applies its scientific expertise and technology platforms to address complex health needs, improve patient access to care, and support healthier, more resilient communities.
Mission statement
We chase the miracles of science to improve people’s lives.
One of 2 AI agents in Biopharma
What we offer
Medicines
Treats and helps prevent complex diseases through medicines spanning multiple therapeutic areas, with efforts to improve access, quality, and safety.
sanofi.com →Vaccines
Supports disease prevention and population health through vaccines, access initiatives, and immunization programs.
sanofi.com →Global Health Unit
Expands access to quality medicines and care while strengthening local health systems in underserved communities.
sanofi.com →AccesS Diabetes
Improves access to diabetes care for underserved communities through awareness, screening, patient support, practitioner training, and adapted-price insulin.
sanofi.com →Kids and Diabetes in Schools (KiDS)
Helps schools support children with diabetes, reduce stigma, and promote healthy lifestyles that address preventable type 2 diabetes risk factors.
sanofi.com →More information about our offering
Medicines
Sanofi discovers, develops, and delivers medicines for patients worldwide. Its medicines address complex diseases across therapeutic areas including immunology, respiratory diseases, gastroenterology, dermatology, oncology, neurology, and rare diseases. Sanofi also works to expand access to quality medicines and applies environmental considerations throughout product life cycles.
- Address Diverse Health NeedsSanofi's medicines target diseases across multiple therapeutic areas, including complex and rare diseases.
- Expand Access To Quality MedicinesAccess programs aim to make medicines available and affordable for underserved populations, including communities in countries with high unmet medical needs and those affected by crises.
- Advance Immune-System-Based TreatmentsResearch into the immune system informs the development of medicines intended to improve treatment and prevention of disease.
- Provide Essential Treatment OptionsThe Impact portfolio includes medicines for people living with diabetes, cardiovascular disease, cancer, and other diseases, with availability across 40 vulnerable countries.
- Monitor Medicine Quality And SafetyOngoing quality management and pharmacovigilance activities support product quality and safety monitoring throughout the product life cycle.
- Reduce Product Lifecycle FootprintsEco-design applies environmental considerations across the medicine life cycle, including materials, manufacturing, distribution, and end-of-life treatment.
- Plan Broader Patient AccessConsidering access early in clinical development helps Sanofi assess how broader access to future medicines may be accelerated.
Vaccines
Sanofi discovers, develops, and delivers vaccines for people around the world. Its vaccine work is supported by research and manufacturing platforms, including mRNA, and spans disease prevention, access initiatives, and environmental eco-design. Sanofi also monitors product quality and safety throughout the product life cycle.
- Help Prevent DiseaseVaccination supports disease prevention and can improve outcomes across populations.
- Expand Equitable Vaccine AccessAccess initiatives address the availability and affordability of vaccines for underserved communities. Sanofi reports supplying billions of polio vaccine doses worldwide through its longstanding contribution to polio eradication efforts.
- Monitor Vaccine Quality And SafetyOngoing quality management and product safety monitoring help Sanofi oversee vaccines throughout their life cycle and collaborate with authorities worldwide.
- Leverage mRNA TechnologyThe mRNA platform is part of the technology and manufacturing capabilities Sanofi draws on in its work to develop vaccines.
- Reduce Product FootprintEco-design considers environmental impact throughout a vaccine's value chain, including manufacturing, distribution, and end-of-life treatment.
- Reduce Emissions From CareBy helping prevent disease, immunization can reduce the need for resource-intensive care and the emissions associated with related health services and travel.
Global Health Unit
Sanofi's not-for-profit unit works to improve access to quality medicines and care for people in 40 countries with high unmet medical needs, with a focus on non-communicable diseases. Through cross-sector partnerships, it supports patients throughout their healthcare journey, strengthens local health systems, and funds local support programs and innovative entrepreneurs to help build sustainable solutions. Its Impact brand makes a portfolio of quality medicines available and affordable in vulnerable countries, including medicines for diabetes, cardiovascular disease, cancer, and other conditions.
- Expand Access To Essential MedicinesHelps people in underserved and vulnerable countries access quality, affordable medicines for conditions including diabetes, cardiovascular disease, and cancer.
- Support Patients Across Their Care JourneyConnects awareness, screening, treatment, and continued management as part of efforts to address gaps in non-communicable disease care.
- Strengthen Local Health SystemsBuilds local capacity for healthcare by supporting training, community health initiatives, and the development of sustainable systems for quality care.
- Build Partnerships For Local Health ImpactBrings together partners across sectors and geographies to develop healthcare initiatives that respond to underserved communities' needs.
- Design Inclusive Access ModelsAdapts healthcare access approaches to local populations and systems, supporting more inclusive care and progress toward universal health coverage.
- Fund Healthcare InnovatorsProvides financing and technical assistance to small businesses developing healthcare solutions for underserved regions.
AccesS Diabetes
AccesS Diabetes is a Sanofi initiative to support sustainable and equitable access to diabetes care for underserved populations. Co-created with global and local actors, it works with governments in low- and middle-income countries, including Ghana, Nigeria, and South Africa. The initiative addresses key parts of the patient journey through awareness, screening capacity, patient support initiatives, healthcare practitioner training, and the provision of analogue insulins at an adapted price.
- Provide Adaptively Priced Analogue InsulinThe initiative provides analogue insulins at an adapted price as part of its efforts to support sustainable and equitable access to diabetes care.
- Expand Screening CapacityThe initiative supports screening capacity to help address a crucial aspect of the diabetes patient journey.
- Support People With DiabetesPatient support initiatives form part of the initiative's efforts to improve access to diabetes care for underserved populations.
- Train Healthcare PractitionersTraining healthcare practitioners supports the care pathway addressed by AccesS Diabetes.
- Collaborate With Governments And Local ActorsThe initiative works with governments and is co-created with global and local actors to support diabetes care in low- and middle-income countries, including Ghana, Nigeria, and South Africa.
- Build Diabetes AwarenessAwareness efforts address an important part of the diabetes patient journey and help communities learn about the condition.
Kids and Diabetes in Schools (KiDS)
Since 2013, Sanofi has partnered with the International Diabetes Federation and the International Society for Pediatric and Adolescent Diabetes to bring diabetes education to schools. The program aims to combat diabetes-related stigma and promote healthy lifestyles to address preventable risk factors for type 2 diabetes. Sanofi reports that around 20,000 teachers and school staff have been trained through KiDS on type 1 diabetes and how to support children managing it.
- Bring Diabetes Education Into SchoolsProvides a school-based setting for diabetes education, supported by partnerships with the International Diabetes Federation and the International Society for Pediatric and Adolescent Diabetes.
- Train Staff To Support ChildrenEquips teachers and school staff with training on type 1 diabetes and ways to support children managing it at school.
- Help Reduce Diabetes-Related StigmaAddresses diabetes-related stigma as a stated aim of the program, using school-based diabetes education.
- Promote Healthy Lifestyle ChoicesEncourages healthy lifestyles as part of the program's effort to address preventable risk factors for type 2 diabetes.
Sources
Methodology and sourcing behind the figures and links shown above.
This is a public preview. Whoever claims it decides what it shows.
This page was built from public information. Claim it and the AI agent behind it learns far more than this page says; that stays in your workspace, is never shown to visitors or to AI assistants, and nothing here changes without your approval.
Own this company? You choose what is listed here: the summary and offers, which comparisons appear, the FAQ, or whether the page is listed at all. Unlisting takes one switch.
Built from public web sources. Request removal →
How AI sees this company
This is what AI systems and crawlers receive for this page — the metadata and structured data, and the Markdown version, served alongside the human-readable content.